Company Filing History:
Years Active: 2017-2022
Title: The Innovative Contributions of Pingping Zhang
Introduction
Pingping Zhang is a prominent inventor based in Cupertino, CA, known for her significant contributions to the field of biotechnology. With a focus on developing therapeutic antibodies, she has made strides in cancer treatment through her innovative research. Zhang holds a total of 4 patents, showcasing her dedication to advancing medical science.
Latest Patents
Among her latest patents, Zhang has developed isolated monoclonal antibodies that target human Cluster of Differentiation 73 (CD73). These antibodies exhibit high affinity for CD73 and inhibit its activity, which is crucial in cancer progression. The patents also include nucleic acid molecules encoding these antibodies, expression vectors, and methods for expressing them. Furthermore, her inventions encompass immunoconjugates, bispecific molecules, and pharmaceutical compositions that utilize these antibodies. Notably, her work provides methods for inhibiting the growth of tumor cells expressing CD73, offering potential treatments for various cancers.
Career Highlights
Zhang is currently employed at Bristol-Myers Squibb Company, where she continues to push the boundaries of cancer research. Her work has been instrumental in developing new therapeutic strategies that leverage the immune system to combat cancer.
Collaborations
Zhang collaborates with esteemed colleagues in her field, including Nils Lonberg and Alan J Korman. These partnerships enhance her research and contribute to the advancement of innovative cancer therapies.
Conclusion
Pingping Zhang's contributions to biotechnology and cancer treatment through her patents and research are commendable. Her work exemplifies the impact of innovation in the medical field, paving the way for future advancements in cancer therapies.